Generic name: atazanavir and cobicistat
Brand names: Evotaz
Class: Combined PI (protease inhibitor) tablets
Common: jaundice (yellowing of the skin and/or eyes), nausea, high blood sugar, increased appetite, change in sense of taste, dry mouth, headache, dizziness, insomnia (difficulty sleeping), abnormal dreams, sleepiness, vomiting, diarrhoea, abdominal pain, indigestion, bloating, flatulence, hyperbilirubinaemia (raised bilirubin levels in the blood), rash, lipodistrophy, fatigue.Rare: irregular heartbeat, allergic reaction, diabetes, depression, peripheral neuropathy, liver problems, kidney problems, gallbladder problems, chest pain.
Tablet comprising 300mg atazanavir and 150mg cobicistat. Cobicistat is a booster drug, which boosts the effect of atazanavir.Take one tablet a day.
Take with food.
*Last reviewed on 03/10/2015 Next review: 03/10/2018
Any questions? Email firstname.lastname@example.org Information included on this website was correct at the time of publication.
Data and image supplied by NAM.
Various people talk about their experiences of living with HIV.
CAB - Citizens Advice Bureau
HIV Drug Interactions
George House Trust
Equality and Human Rights Commission
Copyright 2018 © Terrence Higgins Trust is a registered charity in England and Wales (reg. no. 288527)
Company reg. no. 1778149 and a registered charity in Scotland (reg. no. SC039986). Registered office: 314-320 Gray's Inn Road, London, WC1X 8DP.